Article Details
Retrieved on: 2021-05-14 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SENSCIS-ON is an open-label extension trial of the Phase III SENSCIS® study to assess the long-term tolerability and safety of Ofev® (nintedanib) in ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here